The National Echocardiography Database Australia (NEDA): Rationale and methodology - 30/10/18
Doi : 10.1016/j.ahj.2018.07.001
Geoff Strange a, ⁎ 
, David S Celermajer b, Tom Marwick c, David Prior d, Marcus Ilton e, Jim Codde a, Gregory M Scalia f, Simon Stewart a, Max Bulsara a, Eli Gabbay a, David Playford a
, David S Celermajer b, Tom Marwick c, David Prior d, Marcus Ilton e, Jim Codde a, Gregory M Scalia f, Simon Stewart a, Max Bulsara a, Eli Gabbay a, David Playford a a University of Notre Dame, Fremantle, WA
b Faculty of Medicine and Health, University of Sydney, NSW
c Baker IDI Heart and Diabetes Institute, Melbourne, Vic
d University of Melbourne, St Vincent's Hospital, Melbourne, Vic
e Menzies School of Health Research, Royal Darwin Hospital, NT
f University of QLD, The Prince Charles Hospital, Brisbane, QLD
⁎Reprint requests: Geoff Strange, University of Notre Dame, Henry St, Fremantle, Western Australia, 6160.University of Notre DameHenry StFremantleWestern Australia6160
Abstract |
The National Echocardiography Database Australia (NEDA) is a new echocardiography database collecting digital measurements on both a retrospective and prospective basis. To date, echocardiographic data from 435,133 individuals (aged 61.6 ± 17.9 years) with linkage to 59,725 all-cause deaths during a median of 40 months follow-up have been collected. These data will inform a number of initial analyses focusing on pulmonary hypertension, aortic stenosis and the role of artificial intelligence to facilitate accurate diagnoses of cardiac abnormalities.
Le texte complet de cet article est disponible en PDF.Plan
| RCT# ACTRN12617001387314. |
Crown Copyright © 2018
Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 204
P. 186-189 - octobre 2018 Retour au numéro
Article précédent
- Moving from volume to value for revascularization in stable ischemic heart disease: A review
- Raymond J. Gibbons, William S. Weintraub, Ralph G. Brindis
- A comparison of the effects of selective and non-selective mineralocorticoid antagonism on glucose homeostasis of heart failure patients with glucose intolerance or type II diabetes: A randomized controlled double-blind trial
- Sandra Korol, Michel White, Eileen O’Meara, François Tournoux, Normand Racine, Anique Ducharme, Jean-Lucien Rouleau, Mark Liszkowski, Asmaa Mansour, Martin Jutras, Marie-Claude Guertin, Mathieu Bernier, Joël Lavoie, Grégoire Leclair, Paul-Eduard Neagoe, Diana Chaar, Martin G. Sirois, Simon de Denus
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?